Introduction: A tailored cell panel screening service using hundreds of cancer cell lines with 2D/3D assays and bioinformatics accelerates oncology drug development and cell panel screening service translational success. Navigating the complex landscape of oncology drug discovery can be overwhelming given the sheer number of experimental models av